These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16357394)

  • 1. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
    Harisinghani MG; Saksena MA; Hahn PF; King B; Kim J; Torabi MT; Weissleder R
    AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
    Anzai Y; Piccoli CW; Outwater EK; Stanford W; Bluemke DA; Nurenberg P; Saini S; Maravilla KR; Feldman DE; Schmiedl UP; Brunberg JA; Francis IR; Harms SE; Som PM; Tempany CM;
    Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers.
    Saksena M; Harisinghani M; Hahn P; Kim J; Saokar A; King B; Weissleder R
    AJR Am J Roentgenol; 2006 Dec; 187(6):W582-8. PubMed ID: 17114509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
    Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
    Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H; Tanigawa N; Hiramatsu M; Tatsumi Y; Matsuki M; Narabayashi I
    J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
    Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
    AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA; Jager GJ; Hövels AM; de Hoop B; van den Bosch HC; Raat F; Witjes JA; Mulders PF; van der Kaa CH; Barentsz JO
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
    Harisinghani MG; Dixon WT; Saksena MA; Brachtel E; Blezek DJ; Dhawale PJ; Torabi M; Hahn PF
    Radiographics; 2004; 24(3):867-78. PubMed ID: 15143236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
    Mack MG; Balzer JO; Straub R; Eichler K; Vogl TJ
    Radiology; 2002 Jan; 222(1):239-44. PubMed ID: 11756732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis.
    Will O; Purkayastha S; Chan C; Athanasiou T; Darzi AW; Gedroyc W; Tekkis PP
    Lancet Oncol; 2006 Jan; 7(1):52-60. PubMed ID: 16389184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
    Pandharipande PV; Mora JT; Uppot RN; Goehler A; Braschi M; Halpern EF; Gazelle GS; Harisinghani MG
    AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Tabatabaei S; Harisinghani M; McDougal WS
    J Urol; 2005 Sep; 174(3):923-7; discussion 927. PubMed ID: 16093989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
    Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
    Pannu HK; Wang KP; Borman TL; Bluemke DA
    J Magn Reson Imaging; 2000 Dec; 12(6):899-904. PubMed ID: 11105028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Montie JE
    J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA; Saokar A; Harisinghani MG
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.